Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012- 2018

With growing incidences of cancer, Parkinson’s and Alzheimer’s disease, and metabolic disorders, the global peptide therapeutics market has received a significant boost. The application of peptide therapeutics in the field of biotechnology and pharmaceuticals offers tremendous potential as an emerging market and the research report analyses the numerous possibilities that lie before the global peptide therapeutics market.

Browse Report:http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Categorizing the peptide therapeutics market on the basis of type, application, route of administration, technology, and geography, the report individually evaluates each segment of the peptide therapeutics industry and offers key insights on the same. Data on key aspects such as market size, value, industry share, global outlook, trends, and past, current, and future statistics of the global peptide therapeutics market have been provided and analyzed with the help of graphs, tables, and pie-charts.

The report also identifies growth drivers, inhibitors and opportunities of the peptide therapeutics market, with a detailed section covering the competitive landscape.

Overview of the global peptide therapeutics market
The worldwide market for peptide therapeutics was valued at US$14.1 billion in 2011 and is expected to grow to US$25.4 billion in 2018 at a CAGR of 8.7% during the forecast period.

The prevalence of cancer, Alzheimer’s and Parkinson’s disease, and metabolic disorders has grown in recent years, which has propelled the peptide therapeutics market. Moreover, based on market research, the integration of small peptide therapeutics firms and large pharmaceutical companies will pose tremendous opportunities for growth. In addition to this, possibility of patent cliff in the forecast period is expected to expand the generic peptide segment. 

Advances in technology, increasing R&D activities in the field of peptide therapeutics, and development of cancer vaccines are some of the other forces that drive the global peptide therapeutics market. The factors that restrain the growth of the peptide therapeutics market are difficulties in corresponding equipment with patients’ needs, growing intricacies of peptides, and poor regulatory standards for peptide therapeutics.


Peptide therapeutics are applied in numerous disciplines of medicine such as anti-infection, neurology, cardiovascular, renal, pain, dermatology, respiratory, cancer, gastro intestinal, and metabolic. Of these, cancer peptide enjoys the largest industry share, accounting for 21% of the overall peptide therapeutics market. However, with increasing prevalence of Alzheimer’s and Parkinson’s disease, the neuropeptide segment is expected to witness rapid growth in the forecast period. Among the major routes of peptide therapeutics administration, the parenteral segment made up for 86% of the market share in 2011. Globally, North America dominates the global peptide therapeutics market, making up 40% of the overall industry.



Companies mentioned in the research report

The vendors operating in the global peptide therapeutics market include F. Hoffmann La Roche Ltd., Novo-Nordisk A/S, Eli Lilly and Company, Ipsen, and Amylin Pharmaceuticals LLC (Bristol-Myers Squibb). The CMOs in the global peptide therapeutics market include Peptisyntha, Inc., Lonza, Inc., Bachem Holding AG, and PolyPeptide Group.



Major geographies analyzed under this research report are:

Europe

• North America
  
• Asia-Pacific
  
• Rest of the World
  

This report gives you access to decisive data such as:

• Market growth drivers
  

• Factors limiting market growth
  
• Current market trends
  
• Market structure
  
• Market projections for the coming years
  
• 
  

Key highlights of this report:

• Overview of key market forces propelling and restraining market growth
  
• Up-to-date analyses of market trends and technological improvements in the micro servers industry
  
• Pin-point analyses of market competition dynamics to offer you a competitive edge
  
• An analysis of strategies of major competitors
  
• An array of graphics and SWOT analysis of major industry segments
  
• Detailed analyses of industry trends
  
• A well-defined technological growth map with an impact-analysis
  
• Offers a clear understanding of the competitive landscape and key product segments
  

Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418



About Us :

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 – 2018

The surge in therapeutic research activities led by government support across the world has spurred the growth of the global stem cells market. The research report on the stem cells industry gives a clear understanding of the structure, scope, and dynamics of the market and provides sharp insights on the same.



Browse Report:http://www.transparencymarketresearch.com/stem-cells-market.html



The report provides historic, current, and future data associated with the stem cell market size, share, annual growth, trends, key established and emerging market areas, and potential stem cell markets. With the help of graphs and tables, the report presents estimates and forecasts in a crisp and clear format. Using Porter’s five forces analysis, the report discusses the competitive landscape of the stem cells market, and provides a comprehensive evaluation of the leading market players.



The research report aims to help entities make well-informed business decisions based on accurate data and expert analysis.


Overview of the global stem cells market
The worldwide market for stem cells was worth US$26.23 billion in 2013 and, growing at a 24.2% CAGR, is expected to reach an approximate value of US$119.52 billion by 2019.



As the prevalence of chronic diseases and rate of unmet medical needs grows, so does the number of research activities in the field of stem cells. Government support and funds in the development and clinical research of stem cells has fostered the growth of the stem cells market. In addition, there has been an increase in awareness regarding regenerative treatment options, stem cell banking services, and the need for stem cells in drug discovery and screening. Medical tourism hubs in developing countries such as India, China, Mexico, Brazil, and Malaysia have further helped the growth of the stem cells market especially in Asia and Latin America. There are numerous opportunities that present themselves before the stem cells market such as growth of the contract research industry, rising disposable income in emerging countries, replacing animal tissue in drug discovery, and increasing number of patients with neurodegenerative diseases.



On the other hand, stringent government regulations against the harvesting of stem cells and high cost of treatment are expected to stall the growth of the global market.



The stem cells industry is highly diversified and fragmented, and can be segmented on the basis of products, technology, applications, and geography. The major stem cell product types are human embryonic stem cells, induced pluripotent stem cells, very small embryonic-like stem cells, rat neural stem cells, and adult stem cells. The main technology sub-segments include stem cell cryopreservation, stem cells expansion and sub-culture, stem cell acquisition, and stem cell production. Stem cells find applications in two key sectors: drug discovery and development, and regenerative medicines.



Request a Sample of this Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132



Companies mentioned in the research report



The global stem cells market is prospering with numerous small and big players operating within the industry. Some of the key stem cells market players include Advanced Cell Technology, Celgene Corporation Inc., Cellartis AB, Brainstorm Cell Therapeutics, Biotime Inc., Osiris Therapeutics, California Stem Cell Inc., Angel Biotechnology, Bioheart, Cellular Engineering Technologies, Stemcelltechnologies Inc., and Cytori Therapeutics Inc.



Major geographies analyzed under this research report are:
Europe
North America
Asia-Pacific
Rest of the World



This report gives you access to decisive data such as:
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for the coming years



Key highlights of this report
Overview of key market forces propelling and restraining market growth
Up-to-date analyses of market trends and technological improvements in the micro servers industry
Pin-point analyses of market competition dynamics to offer you a competitive edge
An analysis of strategies of major competitors
An array of graphics and SWOT analysis of major industry segments
Detailed analyses of industry trends
A well-defined technological growth map with an impact-analysis
Offers a clear understanding of the competitive landscape and key product segment\



Request for discount on this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=132

About us:

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact:

Transparency Market Research

90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012- 2018

With growing incidences of cancer, Parkinson’s and Alzheimer’s disease, and metabolic disorders, the global peptide therapeutics market has received a significant boost. The application of peptide therapeutics in the field of biotechnology and pharmaceuticals offers tremendous potential as an emerging market and the research report analyses the numerous possibilities that lie before the global peptide therapeutics market.

Browse Report:http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Categorizing the peptide therapeutics market on the basis of type, application, route of administration, technology, and geography, the report individually evaluates each segment of the peptide therapeutics industry and offers key insights on the same. Data on key aspects such as market size, value, industry share, global outlook, trends, and past, current, and future statistics of the global peptide therapeutics market have been provided and analyzed with the help of graphs, tables, and pie-charts.

The report also identifies growth drivers, inhibitors and opportunities of the peptide therapeutics market, with a detailed section covering the competitive landscape.

Overview of the global peptide therapeutics market
The worldwide market for peptide therapeutics was valued at US$14.1 billion in 2011 and is expected to grow to US$25.4 billion in 2018 at a CAGR of 8.7% during the forecast period.

The prevalence of cancer, Alzheimer’s and Parkinson’s disease, and metabolic disorders has grown in recent years, which has propelled the peptide therapeutics market. Moreover, based on market research, the integration of small peptide therapeutics firms and large pharmaceutical companies will pose tremendous opportunities for growth. In addition to this, possibility of patent cliff in the forecast period is expected to expand the generic peptide segment. Advances in technology, increasing R&D activities in the field of peptide therapeutics, and development of cancer vaccines are some of the other forces that drive the global peptide therapeutics market. The factors that restrain the growth of the peptide therapeutics market are difficulties in corresponding equipment with patients’ needs, growing intricacies of peptides, and poor regulatory standards for peptide therapeutics.


Peptide therapeutics are applied in numerous disciplines of medicine such as anti-infection, neurology, cardiovascular, renal, pain, dermatology, respiratory, cancer, gastro intestinal, and metabolic. Of these, cancer peptide enjoys the largest industry share, accounting for 21% of the overall peptide therapeutics market. However, with increasing prevalence of Alzheimer’s and Parkinson’s disease, the neuropeptide segment is expected to witness rapid growth in the forecast period. Among the major routes of peptide therapeutics administration, the parenteral segment made up for 86% of the market share in 2011. Globally, North America dominates the global peptide therapeutics market, making up 40% of the overall industry.


Companies mentioned in the research report


The vendors operating in the global peptide therapeutics market include F. Hoffmann La Roche Ltd., Novo-Nordisk A/S, Eli Lilly and Company, Ipsen, and Amylin Pharmaceuticals LLC (Bristol-Myers Squibb). The CMOs in the global peptide therapeutics market include Peptisyntha, Inc., Lonza, Inc., Bachem Holding AG, and PolyPeptide Group.



Major geographies analyzed under this research report are:

• Europe
  
• North America
  
• Asia-Pacific
  
• Rest of the World
  

This report gives you access to decisive data such as:

• Market growth drivers
  

• Factors limiting market growth
  
• Current market trends
  
• Market structure
  
• Market projections for the coming years
  
• 
  

Key highlights of this report:

• Overview of key market forces propelling and restraining market growth
  
• Up-to-date analyses of market trends and technological improvements in the micro servers industry
  
• Pin-point analyses of market competition dynamics to offer you a competitive edge
  
• An analysis of strategies of major competitors
  
• An array of graphics and SWOT analysis of major industry segments
  
• Detailed analyses of industry trends
  
• A well-defined technological growth map with an impact-analysis
  
• Offers a clear understanding of the competitive landscape and key product segments
  

Sample Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418



About Us :


Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.



Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

The market growth is majorly attributed to therapeutic research activities led by government support worldwide owing to the growing number of patients with chronic diseases across the globe. In addition, rising awareness of regenerative treatment options and growing importance of stem cell banking services are also fostering the growth of the market. Apart from these, development of medical tourism hubs in developing nations such as India and China and in turn migration of patients from developed nations such as the U.S., and Europe for quality treatment at significantly lower prices will also serve the market as a driver especially for the Asian stem cells market.

Browse the full report at http://www.transparencymarketresearch.com/stem-cells-market.html

Stem cells market will be driven by rising proportion of patients with neurological and other chronic conditions and rising disposable incomes of patients induced by economic growth of Asian regions in the next five years In addition, increasing dependence on stem cells for drug discovery and screening will boost the growth of the market in future. Increased outsourcing of contract research and clinical trials to developing Asian regions will further encourage growth of the stem cells market.

Adult stem cells held majority share of the overall stem cells market in 2011 at over 80%. This is due to less laborious procedure of harvesting, and less probability of contamination during expansion and sub-culture of adult stem cells. However, fewer post-transplant complications and lesser risk of graft vs. host reaction from the recently introduced induced pluripotent stem cells will lead to its rapid inclusion in research activities and help the global induced pluripotent stem cells market to grow at a relatively faster CAGR during the forecast period.

Regenerative medicine dominated the stem cells market by applications in 2011, and is expected to maintain its leading position till 2018. Considerable research activities and the resultant developed therapies in neurology will drive the stem cells market in the forecast period.

North America was the market leader of the total stem cells market in 2011 and is expected to maintain its leading position till 2018. North American market is a center for stem cells research owing to greater support offered by federal government, and higher affordability of treatment in the region. High prevalence of chronic diseases in the region and support in terms of funding from government and private organizations is driving the European stem cells market.

The key players in stem cell research and technology include Advanced Cell Technology Inc., Stem Cell Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., and Cellartis Ab among others.

The global stem cells market is categorized into the following segments:

Stem Cells Market by Products

Adult Stem Cells

Hematopoietic Stem Cells

Mesenchymal Stem Cells

Neuronal Stem Cells

Dental Stem Cells

Umbilical Cord Stem Cells

Human Embryonic Stem Cells

Induced Pluripotent Stem Cells

Natural Rosette Cells

Very Small Embryonic-Like Stem Cells

Stem Cells Market by Technology

Cell Acquisition

Bone Marrow Harvest

Apheresis

Umbilical Cord Blood

Cell Production

Therapeutic Cloning

In Vitro Fertilization

Isolation

Cell Culture

Cryopreservation

Expansion and Sub-Culture

Stem Cells Market by Applications

Regenerative Medicine

Neurological Disorders

Orthopedics

Cancer

Hematological disorders

Cardiovascular diseases

Injuries

Wound Care

Spinal Cord Injury

Others (Joint Injuries, Eye Injuries, Lacerations and Concussions)

Diabetes

Liver Disorder

Incontinence

Others (Crohn's Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)

Drug Discovery and Development

Stem Cells Market by Geography

North America

Europe

--Asia

Rest of the World (RoW)

For Sample Report Visit On:

http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=132

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

The research report, titled “Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, fully explores current and future possibilities in the growing segment of companion diagnostics.

Browse the full Report at

http://www.transparencymarketresearch.com/companion-diagnostics-market.html

The report states that the companion diagnostics market for breast cancer was the dominant sector in 2012, in terms of revenue. The upcoming sector for the near future is lung cancer. The segment is growing at a CAGR of more than 20% between 2013 and 2019. The report cites reasons for growth as the discovery of lung cancer specific biomarkers, along with a myriad of relevant companion diagnostics.

The largest market according to region in 2012 was North America, with the E.U. in following. The report said that the factors that favored the market’s growth were positive healthcare policies, a growing consumer base, increasing disposable incomes, improvements in healthcare systems, and increased awareness. The acceptance of modern medicine into mainstream sectors in the U.S. and the E.U. are the prime reasons for the growth of this market. The Asia-Pacific region and the Rest of the World regions are set to show considerable growth by the year 2019. The report cites untapped potential, increasing disposable incomes, and an improving healthcare infrastructure.

The report explains that companion diagnostics are tests which assist physicians while making decisions regarding the most efficient treatment methods, depending on responses by the patient over ongoing treatment.

Key restraints as explained by the report include regulatory restrictions, commercialization of companion diagnostics, heavy procedure costs, long phases of approval, and lack of reach towards the low income countries.

Key companies in the companion diagnostics market include Quagen N.V., Abbott Laboratories, Life Technologies, Genomic Health, Inc., GE Healthcare Ltd., Roche Holdings AG, Agilent Technologies, Inc., and Agendia N.V.

The report provides exhaustive details on the companion diagnostics market by segmenting it according to indications and geography. By indications, the market is classified into breast cancer, lung cancer, melanoma, gastric cancer, colorectal cancer, and others such as HIV and thalassemia. According to geography, the reports details North America, Europe, Asia-Pacific, and Rest of the World.

About Us

Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

C

Global Peptide Therapeutics Market to Value USD 25.4 Billion by 2018 - Transparency Market Research

Transparency Market Research has announced the addition of a new market intelligence report titled, “Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," to its offering. The report articulates that the global Peptide therapeutics market, which was worth approximately 14.1 billion in 2011, is estimated to grow at an average CAGR of 8.7% and reach an approximate value of USD 25.4 billion at the end of the forecast period that ranges from 2012 to 2018.

Browse Full Peptide Therapeutics Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

Peptides, the polymers that contain less than 50 amino acids and have molecular weights of less than 10 KDa, represent a group of substances with unique pharmacokinetic properties as compared to small molecule drugs and large proteins.

Peptides are known to play essential roles in modulating cellular functions and coordinating intercellular communications of our bodies. Scientists say that, as peptides are made from naturally occurring, metabolically tolerable amino acids, they are usually non toxic. So, the more one can utilize peptides in the making of a drug, the safer the drug shall be.

Peptide drugs also result in a much lesser risk of side-effects because of the close relationship between peptide drug molecules and the parent molecules that they are derived from. Side-effects, if any, when occur due to peptide drugs is most commonly a case of some local reaction or a dosage related issue.

The market for peptide drugs, which was not very developed and popular some decades back, is currently experiencing immense growth.

According to a recent report published by US market intelligence firm Transparency Market Research, the global market for Peptide Therapeutics, slated as

being worth 14.1 billion in the year 2011, is estimated to grow at an average CAGR of 8.7% and reach a value of USD 25.4 billion by the end of 2018.

The report adds that the market growth will be driven by factors such as a global rise in incidences of metabolic and cardiovascular diseases and huge technological developments in the field of peptide manufacturing. Especially, the market is estimated to achieve good growth as a result of enhancements in technology pertaining the introduction of niche methods such as solid phase peptide syntheses and introduction of many hybrid methods that are set to provide the best of both solid and liquid syntheses.

Application wise, this market is anticipated to experience a healthy growth in cancer peptide segment while the segment of neuropeptides is also estimated to grow at a vigorous rate of an average CAGR of 9.4% during the forecasted period. This market shall achieve this growth as a result of the rising cases of neurological disorders around the globe, the report added.

Sample Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418

According to the report, the segment of hybrid technology of peptide synthesis is estimated to experience the highest growth of 12.1% during the forecasted period.

Though the current share of peptide drugs is only near to 1.55% of the overall medicine market, the numbers are dramatically increasing every passing year. The report estimates that currently over 120 new peptide drugs are in their clinical trial phase and some 500 to 600 are in their preclinical trial phases.

The new report on this market offered by Transparency Market Research offers a whole new outlook to the market activities, factors affecting its growth, factors restraining its growth, the various application fields of peptide drugs, the types of drugs currently available in the market, various routes of administration of drugs and the current technologies applied for manufacturing peptide drugs are discussed in detail.

Browse Full Peptide Therapeutics Market Research Report With Complete TOC @ http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with a highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA/Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Web: http://www.transparencymarketresearch.com/